Dandekar Atul sold MAZE
January 29, 2026 · Form 4 insider transaction
Dandekar Atul sold 3,500 shares of Maze Therapeutics, Inc. at $44.04 per share, a transaction worth $154.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,500
Price
$44.04
Total value
$154.1K
InsiderDandekar Atul
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 29, 2026
Filing dateFebruary 2, 2026
Shares owned after13,303
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.51 to $44.49 per share, inclusive.